Israel
Pepticom Ltd., founded in 2011, has positioned itself as a trailblazer in the field of peptide discovery through its proprietary Artificial Intelligence (AI) platform. The company’s slogan, Intelligent Peptide Design, aptly describes its core mission of leveraging AI to innovate in peptide and molecule discovery.
Drawing from research initiated at the Hebrew University and significantly advancing it, Pepticom has developed disruptive technology that dramatically reduces both the time and cost associated with traditional laboratory methods. The company's AI-driven platform enables rapid discovery of high-quality peptides, applicable in pharmaceutical, agricultural, and animal well-being sectors.
Currently, Pepticom is involved in significant projects with industry majors, including ADAMA in agriculture. While specific investment details are not disclosed, the company's pioneering approach positions it as an attractive prospect for venture capital interested in the intersection of biotechnology and AI.
